Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ696,56970,58
KB8538540,83
PKN75,8875,962,26
Msft296,81297,30,00
Nokia4,66754,67251,29
IBM135,4135,730,00
Daimler AG70,0970,111,39
PFE44,4344,540,00
21.09.2021 10:16:41
Indexy online
AD Index online
select
AD Index online
 

  • 20.09.2021
Masimo (MASI.O, NASDAQ Cons)
Závěr k 20.9.2021 Změna (%) Změna (USD) Objem obchodů (ks)
273,11 -0,49 -1,34 168 274
Premarket21.09.2021 10:00:15
Poslední obchod Nákup / Prodej Změna (%) Změna (USD) Objem obchodů (ks)
- 263,20 300,00 - - -
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 21.09.2021
Popis společnosti
Obecné informace
Název společnostiMasimo Corporation
TickerMASI
Kmenové akcie:Ordinary Shares
RICMASI.O
ISIN-
Poslední známé roční výsledky02.01.2021
Poslední známé čtvrtletní výsledky03.07.2021
Počet zaměstnanců k 02.01.2021 1 600
Akcie v oběhu k 03.07.2021 55 057 000
MěnaUSD
Konstituent indexůS&P 400 Mid Cap
Kontaktní informace
Ulice52 Discovery
MěstoIRVINE
PSČ92618-3105
ZeměUnited States
Kontatní osobaEli Kammerman
Funkce kontaktní osobyInvestor Relations Officer
Telefon19 492 977 000
Fax19492977499
Kontatní telefon19 492 977 077

Business Summary: Masimo Corporation is a global medical technology company that develops, manufactures, and markets noninvasive technologies and hospital automation solutions. Its patient monitoring solution that incorporates a monitor or circuit board, single-patient use or reusable sensors, software and cables. The Company’s main products include Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include noninvasive monitoring of blood constituents with an optical signature, optical regional oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring, exhaled gas monitoring, nasal high flow ventilation, minimally invasive neuromodulation technology for pain. It sells its products hospitals, emergency medical service (EMS) providers, home care providers, long-term care facilities, physician offices, veterinarians and consumers through direct sales force, distributors and original equipment manufacturers (OEM) partners.
Financial Summary: BRIEF: For the 26 weeks ended 03 July 2021, MasimoCorporation revenues increased 6% to $604.2M. Net incomedecreased 14% to $103.6M. Revenues reflect United Statessegment increase of 6% to $406.1M, Asia and Australiasegment increase of 30% to $59.3M. Net income was offset byResearch and development increase of 18% to $68.5M(expense), Interest Income decrease of 90% to $435K(income).
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Equipment
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICS2007Electromedical Apparatus Mfg
NAICS2007Surgical & Medical Instrument Mfg
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
NAICS1997Surgical and Medical Instrument Manufacturing
SICElectromedical Equipment
SICElectromedical Equipment
SICSurgical And Medical Instruments



  • Poslední aktualizace: 21.09.2021
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, Chief Executive OfficerJoseph Kiani5601.01.1989
Chief Financial Officer, Executive Vice PresidentMicah Young4216.10.201716.10.2017
Chief Operating OfficerBilal Muhsin40
Executive Vice President, General Counsel, Corporate SecretaryTom McClenahan48
Executive Vice President - Business DevelopmentTao Levy47